Venkatesan Jayaprakash

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 16

Top Venues

Pathogens (Basel, Switzerland)

Biomedicines

Journal of medicinal chemistry

The journal of physical chemistry letters

Birla Institute of Technology

Birla Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Birla Institute of Technology Jul 01 2016

India

Associate Professor :: Department of Pharmaceutical Sciences & Technology

Birla Institute of Technology Jun 01 2007 - Jun 30 2016

India

Assistant Professor :: Department of Pharmaceutical Sciences & Technology

Birla Institute of Technology Feb 16 2004 - May 31 2007

India

Lecturer :: Department of Pharmaceutical Sciences

Education History

Birla Institute of Technology

India

PHD :: Department of Pharmaceutical Sciences

Publications

Ayse Tarbin Jannuzzi, Ayşe Mine Yılmaz Göler, Abanish Biswas, Subodh Mondal, Vinay N Basavanakatti, Hatice Yıldırım, Mahmut Yıldız, Nilüfer Bayrak, Venkatesan Jayaprakash, Amaç Fatih Tuyun
Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile. Biomedicines 12 (6) (2024)
Ayse Tarbin Jannuzzi, Ayşe Mine Yılmaz Göler, Abanish Biswas, Subodh Mondal, Vinay N Basavanakatti, Hatice Yıldırım, Mahmut Yıldız, Nilüfer Bayrak, Venkatesan Jayaprakash, Amaç Fatih Tuyun
Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile. Biomedicines 12 (6) (2024)
Gourav Rakshit, Abanish Biswas, Venkatesan Jayaprakash
In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors. Pathogens (Basel, Switzerland) 12 (12) (2023)
Gourav Rakshit, Abanish Biswas, Venkatesan Jayaprakash
In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors. Pathogens (Basel, Switzerland) 12 (12) (2023)
Gourav Rakshit, Abanish Biswas, Venkatesan Jayaprakash
In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors. Pathogens (Basel, Switzerland) 12 (12) (2023)
Mousumi Shyam, Deepak Shilkar, Gourav Rakshit, Venkatesan Jayaprakash
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand. Expert opinion on drug discovery 17 (7) (2022)
Hatice Yıldırım, Nilüfer Bayrak, Mahmut Yıldız, Fatıma Nur Yılmaz, Emel Mataraci Kara, Deepak Shilkar, Venkatesan Jayaprakash, Amaç Fatih Tuyun
Highly Active Small Aminated Quinolinequinones against Drug-Resistant Staphylococcus aureus and Candida albicans . Molecules (Basel, Switzerland) 27 (9) (2022)
Ayse Tarbin Jannuzzi, Ayşe Mine Yılmaz Göler, Nilüfer Bayrak, Mahmut Yıldız, Hatice Yıldırım, Betul Karademir Yilmaz, Deepak Shilkar, Raghusrinivasan Jayaprakash Venkatesan, Venkatesan Jayaprakash, Amaç Fatih Tuyun
Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Hatice Yıldırım, Nilüfer Bayrak, Mahmut Yıldız, Emel Mataracı-Kara, Serol Korkmaz, Deepak Shilkar, Venkatesan Jayaprakash, Amaç Fatih Tuyun
Aminated Quinolinequinones as Privileged Scaffolds for Antibacterial Agents: Synthesis, In Vitro Evaluation, and Putative Mode of Action. ACS omega 7 (46) (2022)
Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, Piyali Mukherjee, Samsher Singh, Sujit Kamilya, Pushpendu Jalani, Swetarka Das, Arunava Dasgupta, Abhishake Mondal, Amit Kumar Das, Amit Singh, Federico Brucoli, Claire Bagnéris, Rachael Dickman, Vinay N Basavanakatti, Patibandla Naresh Babu, Vadivelan Sankaran, Abhimanyu Dev, Barij Nayan Sinha, Sanjib Bhakta, Venkatesan Jayaprakash
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition. Journal of medicinal chemistry 65 (1) (2022)
Abhishek Thakur, Gaurav Sharma, Vishnu Nayak Badavath, Venkatesan Jayaprakash, Kenneth M Merz, Galia Blum, Orlando Acevedo
Primer for Designing Main Protease (M pro ) Inhibitors of SARS-CoV-2. The journal of physical chemistry letters 13 (25) (2022)
Mousumi Shyam, Deepak Shilkar, Harshita Verma, Abhimanyu Dev, Barij Nayan Sinha, Federico Brucoli, Sanjib Bhakta, Venkatesan Jayaprakash
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis. Journal of medicinal chemistry 64 (1) (2020)
Rana Abdelnabi, James A Geraets, Yipeng Ma, Carmen Mirabelli, Justin W Flatt, Aušra Domanska, Leen Delang, Dirk Jochmans, Timiri Ajay Kumar, Venkatesan Jayaprakash, Barij Nayan Sinha, Pieter Leyssen, Sarah Jane Butcher, Johan Neyts
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS biology 17 (6) (2019)
Manisha Choudhury, Vijayan Viswanathan, Ajay Kumar Timiri, Barij Nayan Sinha, Venkatesan Jayaprakash, Devadasan Velmurugan
Crystal structures and Hirshfeld surface analyses of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(pyridin-2-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]-N-(pyrazin-2-yl)acetamide. Acta crystallographica. Section E, Crystallographic communications 74 (Pt 5) (2018)
Chandrani Nath, Vishnu Nayak Badavath, Abhishek Thakur, Gulberk Ucar, Orlando Acevedo, Mohd Usman Mohd Siddique, Venkatesan Jayaprakash
Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A. MedChemComm 9 (7) (2018)
Sabina Yasmin, Fabio Capone, Antonio Laghezza, Fabrizio Dal Piaz, Fulvio Loiodice, Viswanathan Vijayan, Velmurugan Devadasan, Susanta K Mondal, Özlem Atlı, Merve Baysal, Ashok K Pattnaik, Venkatesan Jayaprakash, Antonio Lavecchia
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes. Scientific reports 7 (1) (2017)
Rathinavelusamy Paramaguru, Papiya Mitra Mazumder, Dinakar Sasmal, Venkatesan Jayaprakash
Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint. BioMed research international 2014 (2014)

Venkatesan Jayaprakash.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Venkatesan Jayaprakash